| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/11/2006 | 22:02 | Business Wire | Gilead Sciences Completes Acquisition of Myogen | NASDAQ:MYOG | Myogen |
| 06/11/2006 | 14:00 | Business Wire | Darusentan Data to Be Presented at AHA 2006 -- Chicago | NASDAQ:MYOG | Myogen |
| 17/10/2006 | 22:00 | Business Wire | Darusentan Data to Be Presented at ISH 2006 -- Fukuoka, Japan | NASDAQ:MYOG | Myogen |
| 10/10/2006 | 14:00 | Business Wire | Four Ambrisentan Studies to Be Presented at Chest 2006 -- Salt Lake City | NASDAQ:MYOG | Myogen |
| 02/10/2006 | 18:11 | PR Newswire (US) | Seven Summits Research Releases Comments on GOOG, ABX, HET, CBS, and MYOG | NASDAQ:MYOG | Myogen |
| 02/10/2006 | 13:00 | Business Wire | Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion | NASDAQ:MYOG | Myogen |
| 20/09/2006 | 14:30 | Business Wire | Myogen to Present at the UBS Global Life Sciences Conference | NASDAQ:MYOG | Myogen |
| 07/09/2006 | 14:00 | Business Wire | Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension | NASDAQ:MYOG | Myogen |
| 06/09/2006 | 14:00 | Business Wire | The American Lung Association and Myogen Announce Pulmonary Arterial Hypertension Educational Partnership | NASDAQ:MYOG | Myogen |
| 07/08/2006 | 22:00 | Business Wire | Myogen Reports 2006 Second Quarter Results | NASDAQ:MYOG | Myogen |
| 25/07/2006 | 13:45 | Business Wire | Myogen to Announce 2006 Second Quarter Results on August 7, 2006 | NASDAQ:MYOG | Myogen |
| 11/07/2006 | 14:30 | Business Wire | Myogen Announces Extension of Drug Discovery Collaboration | NASDAQ:MYOG | Myogen |
| 08/06/2006 | 13:30 | Business Wire | Myogen to Present at the Goldman Sachs Global Healthcare Conference | NASDAQ:MYOG | Myogen |
| 05/06/2006 | 14:01 | Business Wire | Myogen Initiates Phase 3 Clinical Trial of Darusentan in Patients with Resistant Hypertension | NASDAQ:MYOG | Myogen |
| 24/05/2006 | 12:30 | Business Wire | Ambrisentan Phase 3 ARIES-2 PAH Data Presented At ATS 2006 -- San Diego; Significant Improvement in Six-Minute Walk Distance an | NASDAQ:MYOG | Myogen |
| 08/05/2006 | 13:00 | Business Wire | Myogen Reports 2006 First Quarter Results | NASDAQ:MYOG | Myogen |
| 03/05/2006 | 22:00 | Business Wire | Myogen Reports Results for the Integrated Analysis of ARIES-1 and ARIES-2 Pivotal Trials of Ambrisentan in Pulmonary Arterial H | NASDAQ:MYOG | Myogen |
| 21/04/2006 | 13:00 | Business Wire | Myogen to Announce 2006 First Quarter Results on May 8, 2006 | NASDAQ:MYOG | Myogen |
| 19/04/2006 | 22:00 | Business Wire | Myogen to Present at the Leerink Swann Vascular Modlulation Conference | NASDAQ:MYOG | Myogen |
| 10/04/2006 | 18:36 | PR Newswire (US) | Seven Summits Research releases comments on AAPL, EBAY, HAL, MYOG, and URBN | NASDAQ:MYOG | Myogen |
| 10/04/2006 | 13:00 | Business Wire | Myogen Reports Positive Top Line Results for Second Ambrisentan Pivotal Phase 3 Trial in Pulmonary Arterial Hypertension; ARIES | NASDAQ:MYOG | Myogen |
| 09/03/2006 | 16:57 | PR Newswire (US) | Seven Summits Research Releases Comments on MRVL, DELL, SGP, GENZ, and MYOG | NASDAQ:MYOG | Myogen |
| 09/03/2006 | 14:00 | Business Wire | Ambrisentan Receives FDA Fast Track Designation for PAH Development | NASDAQ:MYOG | Myogen |
| 06/03/2006 | 22:10 | Business Wire | Myogen Reports 2005 Results | NASDAQ:MYOG | Myogen |
| 02/03/2006 | 14:00 | Business Wire | Ambrisentan ARIES-2 Data to Be Presented at ATS 2006 -- San Diego | NASDAQ:MYOG | Myogen |
| 28/02/2006 | 22:00 | Business Wire | Myogen to Present at the Citigroup Small & Mid-Cap Conference | NASDAQ:MYOG | Myogen |
| 13/02/2006 | 14:30 | PR Newswire (US) | Myogen Reports Positive Top Line Results for Ambrisentan LFT Rescue Study In Pulmonary Arterial Hypertension | NASDAQ:MYOG | Myogen |
| 06/02/2006 | 16:12 | PR Newswire (US) | NASDAQ Hosts First-Ever Investor Conference in London for Small Cap Companies | NASDAQ:MYOG | |
| 06/02/2006 | 14:00 | PR Newswire (US) | Myogen to Announce 2005 Results on March 6, 2006 | NASDAQ:MYOG | Myogen |
| 02/02/2006 | 22:30 | PR Newswire (US) | Myogen Announces Sale of Myogen GmbH | NASDAQ:MYOG | Myogen |